Collectively, these findings demonstrate that dual PI3K/PD-L1 inhibition moderately inhibits tumor development in a highly aggressive experimental murine HNSCC model, which is in part associated with reduced PD-L1 expression on M1 macrophages. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.